Development and Validation of a 29-Color Immunophenotyping panel for the 3-laser Cytek Northern Lights

Evaluation of PBMC Isolation Methods and the Impact of Cryopreservation

Mutational signatures in PDXs for improved understanding of drug response and companion biomarkers identification

Systematic Analysis of Gene Mutations and Therapeutic Efficacy via Ex vivo Hematological VitroScreen Platform

A Novel Gene Signature predicting fibroblast composition in the TME allows for an improved selection of PDX models for preclinical studies

Unveiling the Correlation between gemtuzumab-ozogamicin Efficacy and CD33+ Expression in AML Primary Samples Using the Novel AML VitroScreen

Bioluminescent 3D Tumors with Immune Cell Co-culture for High Throughput Screening (HTS)

Tumor-on-Chip Co-culture System: An Innovative Tool in Personalized Medicine to Investigate Cancer Progression

A Novel 3D Co-Culture Platform for Patient-Specific Immune-Oncology Treatment

An Innovative PDX and Patient-derived 3D Platform for Improved Translatability of New Medical Entities

Immunophenotyping via High Complexity Flow Cytometry in Acute Myeloid Leukemia

Development of a Flow Cytometric Receptor Occupancy Assay for Clinical Analysis of Immune Checkpoint Inhibitor Therapeutics - SITC 2023

Primary, Fully Characterized Autologous AML System allows the Correlation of T Cell Activation with Leukemia Cell Survival upon Io Treatment in a Novel Autologous System - SITC 2024

Ex Vivo Modeling of Multiple Myeloma: A Novel Drug Sensitivity Screening Platform - AACR 2023

In Vitro Drug Sensitivity Screening Platform for Chronic Lymphocytic Leukemia (CLL) Patient Samples - AACR 2021

In Vitro and In Vivo Model for Evaluation of Novel Therapeutic Agents in Patient-derived Lymphoblastic Leukemia (B-ALL) - AACR 2021

2D Ex Vivo Patient-Derived Acute Myeloid Leukemia Platform for Evaluation of Novel Molecular Targeted Therapeutic Agents - AACR 2020

Development of a Non-small cell lung cancer PDX model in a myeloid-boosted humanized host highlights an M2 polarization phenotype within the myeloid compartment - SITC 2023

A Novel Gene Signature predicts immune infiltration phenotypes in humanized Patient-Derived Xenograft Models - SITC 2023

Natural Killer (NK) Human Immune System (HIS) ImmunoGraft^® Platform to Evaluate the Pharmacodynamics of Immuno-Oncology Therapeutics - AACR 2020

Unique Immunodeficient Murine Host Strains Impact Expansion and Engraftment of T Cells in PBMC Humanized Mice - NYAS 2019

Development of a Peripheral Blood Mononuclear Cells (PBMC) ImmunoGraft^® Platform to Evaluate of the Pharmacodynamics of Immuno Oncology Therapeutics - SITC 2019

Computational deconvolution identifies a Th2-enriched immune-inflammatory signature in invasive breast carcinoma - SITC 2023

A Pharmaco-Pheno-Multiomic Integration Analysis of Pancreatic Cancer: A Highly Predictive Biomarker Model of Biomarkers of Gemcitabine/Abraxane Sensitivity and Resistance - AACR 2023

Multiomic Approaches to Illuminate Molecular Drivers of Breast Cancer Metastasis to the Liver - AACR 2023

A Pharmaco-Pheno-Multiomic Integration Analysis of Primary Acute Myeloid Leukemia Reveals Biomarkers of Cytarabine Resistance - AACR 2022

Pharmaco-Pheno-Multiomic Integration Builds A Biomarker Network of Olaparib Resistance in Ovarian Cancer - AACR 2022

Raptamer-Drug Conjugates as Molecularly Targets Cancer Therapeutics - AACR 2023

Combining Multiomics and Histological Assessment to Identify Patient-derived Xenograft Models of Invasive Lobular Carcinoma - San Antonio Breast Cancer Symposium 2022

Primary, fully characterized autologous AML system allows the correlation of T cell activation with leukemia cell survival upon IO treatment in a novel autologous system - SITC 2024

A Novel TumorGraft3D immune co-culture platform for high throughput immune-oncology screening - SITC 2023

Establishment of Tumor-on-Chip system to study the role of tumor microenvironment on cancer progression in a patient-specific manner - SITC 2023

Identification of synergistic combination of molecular targeted agents and chemotherapy using TumorGraft3D and Lumin platform - Tumor Models Boston 2023

Unique 3D Organoids Autologous TIL Co-Culture Platform Enables High Throughput Immune-Oncology Drug Response Studies - AACR 2021

3D Co-Culture Platform Reveals Insights into Patient Autologous Immune Cell-Tumor Interaction and Immune Modulation In Vitro - SITC 2021

Development of a 3D Organoid Autologous TIL Co-Culture Platform for High Throughput Immuno-Oncology Studies - SITC 2020